These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study. Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P; Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848 [TBL] [Abstract][Full Text] [Related]
24. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City. Vélez Pintado M; Camiro-Zúñiga A; Aguilar Soto M; Cuenca D; Mercado M; Crabtree-Ramirez B; Med Mycol; 2021 Jul; 59(8):828-833. PubMed ID: 33724423 [TBL] [Abstract][Full Text] [Related]
25. COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis. Frost J; Gornicec M; Reisinger AC; Eller P; Hoenigl M; Prattes J Mycopathologia; 2024 Jan; 189(1):3. PubMed ID: 38217742 [TBL] [Abstract][Full Text] [Related]
26. Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study. Bergmann F; Jorda A; Blaschke A; Gabler C; Bohdan S; Nussbaumer-Pröll A; Radtke C; Zeitlinger M J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983483 [TBL] [Abstract][Full Text] [Related]
27. Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients. Leistner R; Schroeter L; Adam T; Poddubnyy D; Stegemann M; Siegmund B; Maechler F; Geffers C; Schwab F; Gastmeier P; Treskatsch S; Angermair S; Schneider T Crit Care; 2022 Jan; 26(1):30. PubMed ID: 35090528 [TBL] [Abstract][Full Text] [Related]
28. Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography. Baratella E; Roman-Pognuz E; Zerbato V; Minelli P; Cavallaro MFM; Cova MA; Luzzati R; Lucangelo U; Sanson G; Friso F; Bussani R; Pinamonti M; Busetti M; Salton F; Confalonieri M; Ruaro B; Di Bella S Front Biosci (Landmark Ed); 2021 Dec; 26(12):1607-1612. PubMed ID: 34994174 [TBL] [Abstract][Full Text] [Related]
29. Analysis of cases with co-infection of COVID-19 and pulmonary aspergillosis. Zheng Hu H; Wu LB; Liu Q; Wu BY; Wang Y; Wang RY New Microbiol; 2024 May; 47(1):98-102. PubMed ID: 38700889 [TBL] [Abstract][Full Text] [Related]
30. Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit. Fumarola B; Signorini L; Lorenzotti S; Lanza P; Saccani B; Van Hauwermeiren E; Mulè A; Piva S; Rota M; Zuccalà F; Rasulo FA; Filippini M; Bertazzoli A; Del Fabro G; Matteelli A Infection; 2024 Aug; 52(4):1459-1468. PubMed ID: 38530518 [TBL] [Abstract][Full Text] [Related]
31. COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan. Nasir N; Farooqi J; Mahmood SF; Jabeen K Mycoses; 2020 Aug; 63(8):766-770. PubMed ID: 32585069 [TBL] [Abstract][Full Text] [Related]
32. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M; Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093 [TBL] [Abstract][Full Text] [Related]
33. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation. Feys S; Lagrou K; Lauwers HM; Haenen K; Jacobs C; Brusselmans M; Debaveye Y; Hermans G; Hoenigl M; Maertens J; Meersseman P; Peetermans M; Spriet I; Vandenbriele C; Vanderbeke L; Vos R; Van Wijngaerden E; Wilmer A; Wauters J Clin Infect Dis; 2024 Feb; 78(2):361-370. PubMed ID: 37691392 [TBL] [Abstract][Full Text] [Related]
34. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study. Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087 [TBL] [Abstract][Full Text] [Related]
35. Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave. Bentvelsen RG; Arkel ALEV; Rijpstra TA; Kant MKM; Brugge SVS; Loth DW; Van Wijngaarden P; Mée AWFD; Yick DCY; Diederen BMW; Wever PC; Leenders ACAP; Van Dommelen L; Groot KH; Van den Bijllaardt W; Verweij PE J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205851 [TBL] [Abstract][Full Text] [Related]